期刊
COLLOIDS AND SURFACES B-BIOINTERFACES
卷 76, 期 1, 页码 362-365出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2009.10.009
关键词
Polydiacetylene; Drug carrier; Sustained-release; Paclitaxel
资金
- National High Technology Research and Development Program of China [2007AA03Z316]
- Ministry of Education of China [707021]
- Natural Scientific Research Innovation Foundation in Harbin Institute of Technology (HIT. NSRIF) [AUWQ18400004]
- HIT [AUGA41400030]
- Key Lab of Urban Water Resource and Environment [2009TS01]
Aiming at the enhancement of the physicochemical stability as well as the sustained-release property of conventional liposomes, a novel polymerized vesicular carrier, 10,12-pentacosadiynoic acid (PCDA) vesicles. loaded with paclitaxel as a model hydrophobic drug has been Successfully constituted by incorporation of a polymerizable diacetylene into the lipid bilayer vesicles. The polymerized vesicles have been characterized in terms of particle size distribution and zeta-potential. Altering their lipid composition causes the zeta-potential to change from -3 +/- 1 mV to more than -25 mV, with a concomitant change in particle size distribution from 29 +/- 4 rum to 149 +/- 18 nm. Dynamic light scattering (DLS) showed that the stability of polymerized vesicles against Triton X-100 was improved greatly compared with the conventional liposomes. In vitro drug release studies show that PCDA-incorporating Vesicles reduce the paclitaxel release over the conventional phospholipids vesicles. 69 +/- 6% paclitaxel is released within 24h from the conventional vesicles, but the insertion of 50% and 75% molar ratio of PCDA changes the amount to 57 +/- 1% and 32 +/- 4%, respectively. Our results demonstrate that such novel polymerized vesicles have very good prospect as an anticancer drug carrier. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据